Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Биовет" АдfiledCritical"Биовет" Ад
Priority to BG101703ApriorityCriticalpatent/BG63072B1/en
Publication of BG101703ApublicationCriticalpatent/BG101703A/en
Publication of BG63072B1publicationCriticalpatent/BG63072B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The form is used in the veterinary medicine practice in thecontrol of helminthosis - nematodiasis and trematodosis inruminants. It contains the usual auxiliary substances andcombination of avermectine and closantel and its soluble salts.The ratio between the avermectines and closantel is from 1:12 to1:80. The combination of active ingredients is the above ratioshows synergism.
BG101703A1997-06-301997-06-30Antiparasitic medicamentous form and method for its application
BG63072B1
(en)
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERTENSION OF BLOOD CONTAINING AN INHIBITOR OF THE ANGIOTENSIN CONVERSATION ENZYME IN SYNERGIC MIX WITH A DIURETIC DRAG AGENT